查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945345

2026年免疫组织化学（IHC）全球市场报告

Immunohistochemistry (IHC) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫组织化学（IHC）市场发展迅速，预计将从2025年的27.6亿美元成长到2026年的30.5亿美元，复合年增长率（CAGR）为10.3%。过去几年的成长可归因于IHC在癌症诊断中应用日益广泛、医院病理检查室规模扩大、单株抗体供应增加、组织学诊断方法的普及以及临床研究活动的增加。

预计未来几年免疫组织化学 (IHC) 市场将快速成长，到 2030 年市场规模将达到 44.7 亿美元，复合年增长率 (CAGR) 为 10.1%。预测期内的成长要素包括：对精准肿瘤诊断的需求不断增长、人工智慧病理分析的日益普及、生物标记主导药物研发的进展、多重组织分析技术的广泛应用以及对先进病理基础设施投资的增加。预测期内的主要趋势包括：自动化 IHC 染色系统的日益普及、多重 I​​HC 技术的广泛应用、数位病理平台的日益整合、伴随诊断应用的扩展以及对高特异性抗体的日益关注。

未来几年，对个人化医疗日益增长的需求预计将推动免疫组织化学 (IHC) 市场的成长。个人化医疗是指根据患者的基因组成、环境因素和生活方式，客製化医疗决策、治疗方法和产品的医疗方法。免疫组织化学在这一方法中发挥关键作用，它能够识别特定的蛋白质生物标记物，从而有助于肿瘤的准确分类和诊断。例如，根据美国非营利研究机构个人化医疗联盟 (Personalized Medicine Coalition) 的数据显示，截至 2024 年 2 月，美国食品药物管理局(FDA) 2023 年新核准中，超过三分之一是与个人化医疗相关的产品。同年，FDA核准了16 种针对罕见疾病患者的新型个人化治疗方法，较 2022 年的 6 种显着增加。因此，个人化医疗的日益普及正在推动免疫组织化学市场的成长。

免疫组织化学 (IHC) 市场的主要企业致力于透过创新技术和高品质试剂来提高诊断准确性，从而增强组织分析在各种临床和研究环境中的有效性。 Neoflex 多体学质谱成像 (MSI) 系统是一个尖端的成像平台，专为精确的组织分析而设计，使研究人员能够利用高解析度质谱技术对组织内的生物分子进行空间定位，从而将研究成果转化为临床应用。例如，2024 年 6 月，总部位于美国的科学仪器、分析和诊断解决方案开发商和製造商 Bruker 发布了 Neoflex 成像分析仪，该系统采用基质辅助雷射解吸/电离飞行时间(MALDI-TOF/TOF) 技术进行基于质谱的组织成像。 Neoflex MSI 系统满足了从发现成像到临床组织研究的进步需求。它配备了布鲁克 10 kHz SmartBeam 3D 雷射器、改进的成像检测器，并支援使用 SCiLS Scope 软体输出 OME-TIFF 檔案。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球免疫组织化学（IHC）市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧与自主智能
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 自动化免疫组织化学染色法系统的应用日益广泛
    • 多重免疫组化技术的应用日益广泛
    • 数位病理平台整合程度不断提高
    • 扩大伴随诊断应用范围
    • 人们对高特异性抗体的兴趣日益浓厚

第五章 终端用户产业市场分析

  • 医院和诊断检查室
  • 研究所
  • 製药公司
  • 生技公司
  • CRO（受託研究机构）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球免疫组织化学（IHC）市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球免疫组织化学 (IHC) 市场规模、比较和成长率分析
  • 全球免疫组织化学（IHC）市场表现：规模与成长，2020-2025年
  • 全球免疫组织化学 (IHC) 市场预测：规模与成长，2025-2030 年，2035 年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 抗体、仪器、试剂和试剂盒
  • 透过使用
  • 诊断、药物检测及其他用途
  • 最终用户
  • 医院、诊断检查室、研究实验室和其他最终用户
  • 按类型细分：抗体
  • 一抗、二抗、标记抗体
  • 按类型细分：设备
  • IHC染色系统、玻片扫描器、显微镜
  • 按类型细分：试剂
  • 检测试剂、封闭试剂、封片剂
  • 按类型细分：套装
  • 製备型免疫组织化学试剂盒、多重免疫组化试剂盒及特殊试剂盒

第十章 区域与国家分析

  • 全球免疫组织化学 (IHC) 市场：区域分析、预测与趋势，2020-2025 年、2025-2030 年预测、2035 年预测
  • 全球免疫组织化学 (IHC) 市场：按国家、表现和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 免疫组织化学（IHC）市场：竞争格局与市场份额，2024年
  • 免疫组织化学 (IHC) 市场：公司估值矩阵
  • 免疫组织化学（IHC）市场：公司简介
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche AG
    • Merck Group
    • Danaher Corporation
    • PerkinElmer Inc.

第37章：其他领先和创新企业

  • Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年免疫组织化学（IHC）市场：提供新机会的国家
  • 2030年免疫组织化学（IHC）市场：充满新机会的细分市场
  • 2030年免疫组织化学（IHC）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MIIHC01_G26Q1

Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.

The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.

Tariffs are influencing the immunohistochemistry market by increasing costs of imported antibodies, reagents, staining systems, slide scanners, and imaging components used in diagnostic and research workflows. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-quality antibodies and equipment, while Asia-Pacific faces cost pressures in reagent exports. These tariffs are raising operational costs and delaying equipment upgrades. However, they are also supporting local antibody production, regional reagent manufacturing, and domestic development of automated IHC systems.

The immunohistochemistry (ihc) market research report is one of a series of new reports from The Business Research Company that provides immunohistochemistry (ihc) market statistics, including immunohistochemistry (ihc) industry global market size, regional shares, competitors with a immunohistochemistry (ihc) market share, detailed immunohistochemistry (ihc) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (ihc) industry. This immunohistochemistry (ihc) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohistochemistry (ihc) market size has grown rapidly in recent years. It will grow from $2.76 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing use of ihc in cancer diagnostics, expansion of hospital pathology laboratories, increased availability of monoclonal antibodies, rising adoption of tissue-based diagnostics, growing clinical research activities.

The immunohistochemistry (ihc) market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising adoption of ai-enabled pathology analysis, expansion of biomarker-driven drug development, growing use of multiplex tissue profiling, increasing investments in advanced pathology infrastructure. Major trends in the forecast period include increasing adoption of automated ihc staining systems, rising use of multiplex ihc techniques, growing integration of digital pathology platforms, expansion of companion diagnostic applications, enhanced focus on high-specificity antibodies.

The increasing demand for personalized medicines is anticipated to accelerate the growth of the immunohistochemistry (IHC) market in the coming years. Personalized medicine refers to a healthcare approach that customizes medical decisions, treatments, and products to individual patients based on their genetic makeup, environmental factors, and lifestyle attributes. Immunohistochemistry plays a crucial role in this approach by enabling the identification of specific protein biomarkers that support precise tumor classification and accurate diagnosis. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit research organization, personalized medicines represented more than one-third of all new approvals by the United States Food and Drug Administration in 2023. During the same year, the FDA approved 16 new personalized therapies for rare disease patients, compared to six approvals in 2022. As a result, the rising adoption of personalized medicines is contributing to the expansion of the immunohistochemistry market.

Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.

In December 2023, Danaher Corporation, a United States-based life sciences and diagnostics company, acquired Abcam plc for an undisclosed value. Through this acquisition, Danaher sought to broaden its portfolio of life science reagents and consumables, strengthen its protein analysis tools for both research and diagnostic applications, accelerate growth across the life sciences ecosystem, and enhance its global presence by offering more integrated solutions to researchers and healthcare professionals. Abcam plc is a United Kingdom-based biotechnology company specializing in antibodies, reagents, assays, and immunohistochemistry products.

Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech

North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohistochemistry (IHC) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immunohistochemistry (ihc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohistochemistry (ihc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohistochemistry (ihc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Antibodies; Equipment; Reagents; Kits
  • 2) By Applications: Diagnostics; Drug Testing; Other Applications
  • 3) By End-Users: Hospitals And Diagnostic Laboratories; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Antibodies: Primary Antibodies; Secondary Antibodies; Conjugated Antibodies
  • 2) By Equipment: IHC Staining Systems; Slide Scanners; Microscopes
  • 3) By Reagents: Detection Reagents; Blocking Reagents; Mounting Media
  • 4) By Kits: Pre-prepared IHC Kits; Multiplex IHC Kits; Specialty Kits
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; Merck Group; Danaher Corporation; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB Inc.; Agilent Technologies Inc.; Abcam plc; Takara Bio Inc.; Biocare Medical LLC; Bio-Genex Laboratories; Diagnostic BioSystems Inc.; PHC Holdings Corporation; Leica Biosystems; Vector Laboratories; Ionpath Inc.; Reveal Biosciences; Akrivis Technologies Private Limited; LifeSpan BioSciences Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; GenScript Biotech
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Immunohistochemistry (IHC) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Immunohistochemistry (IHC) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Immunohistochemistry (IHC) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Immunohistochemistry (IHC) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Automated Ihc Staining Systems
    • 4.2.2 Rising Use Of Multiplex Ihc Techniques
    • 4.2.3 Growing Integration Of Digital Pathology Platforms
    • 4.2.4 Expansion Of Companion Diagnostic Applications
    • 4.2.5 Enhanced Focus On High-Specificity Antibodies

5. Immunohistochemistry (IHC) Market Analysis Of End Use Industries

  • 5.1 Hospitals And Diagnostic Laboratories
  • 5.2 Research Institutes
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Contract Research Organizations

6. Immunohistochemistry (IHC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunohistochemistry (IHC) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Immunohistochemistry (IHC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Immunohistochemistry (IHC) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Immunohistochemistry (IHC) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Immunohistochemistry (IHC) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunohistochemistry (IHC) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunohistochemistry (IHC) Market Segmentation

  • 9.1. Global Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Equipment, Reagents, Kits
  • 9.2. Global Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostics, Drug Testing, Other Applications
  • 9.3. Global Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users
  • 9.4. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
  • 9.5. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • IHC Staining Systems, Slide Scanners, Microscopes
  • 9.6. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Detection Reagents, Blocking Reagents, Mounting Media
  • 9.7. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

10. Immunohistochemistry (IHC) Market Regional And Country Analysis

  • 10.1. Global Immunohistochemistry (IHC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Immunohistochemistry (IHC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunohistochemistry (IHC) Market

  • 11.1. Asia-Pacific Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunohistochemistry (IHC) Market

  • 12.1. China Immunohistochemistry (IHC) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunohistochemistry (IHC) Market

  • 13.1. India Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunohistochemistry (IHC) Market

  • 14.1. Japan Immunohistochemistry (IHC) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunohistochemistry (IHC) Market

  • 15.1. Australia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunohistochemistry (IHC) Market

  • 16.1. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunohistochemistry (IHC) Market

  • 17.1. South Korea Immunohistochemistry (IHC) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunohistochemistry (IHC) Market

  • 18.1. Taiwan Immunohistochemistry (IHC) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunohistochemistry (IHC) Market

  • 19.1. South East Asia Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunohistochemistry (IHC) Market

  • 20.1. Western Europe Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunohistochemistry (IHC) Market

  • 21.1. UK Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunohistochemistry (IHC) Market

  • 22.1. Germany Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunohistochemistry (IHC) Market

  • 23.1. France Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunohistochemistry (IHC) Market

  • 24.1. Italy Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunohistochemistry (IHC) Market

  • 25.1. Spain Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunohistochemistry (IHC) Market

  • 26.1. Eastern Europe Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunohistochemistry (IHC) Market

  • 27.1. Russia Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunohistochemistry (IHC) Market

  • 28.1. North America Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunohistochemistry (IHC) Market

  • 29.1. USA Immunohistochemistry (IHC) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunohistochemistry (IHC) Market

  • 30.1. Canada Immunohistochemistry (IHC) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunohistochemistry (IHC) Market

  • 31.1. South America Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunohistochemistry (IHC) Market

  • 32.1. Brazil Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunohistochemistry (IHC) Market

  • 33.1. Middle East Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunohistochemistry (IHC) Market

  • 34.1. Africa Immunohistochemistry (IHC) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Immunohistochemistry (IHC) Market, Segmentation By Product, Segmentation By Applications, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunohistochemistry (IHC) Market Regulatory and Investment Landscape

36. Immunohistochemistry (IHC) Market Competitive Landscape And Company Profiles

  • 36.1. Immunohistochemistry (IHC) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Immunohistochemistry (IHC) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Immunohistochemistry (IHC) Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Immunohistochemistry (IHC) Market Other Major And Innovative Companies

  • Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited

38. Global Immunohistochemistry (IHC) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunohistochemistry (IHC) Market

40. Immunohistochemistry (IHC) Market High Potential Countries, Segments and Strategies

  • 40.1 Immunohistochemistry (IHC) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Immunohistochemistry (IHC) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Immunohistochemistry (IHC) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer